You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ST-1898, renal cell carcinoma

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Cell Carcinoma Trial (Cytoreductive Nephrectomy)

Not yet recruiting
  • Renal Cell Carcinoma
  • Cytoreductive Nephrectomy
  • (no location specified)
Jul 3, 2023

Renal Cell Carcinoma Metastases to Pancreas

Completed
  • Surgery
    • (no location specified)
    May 21, 2023

    Renal Cell Carcinoma Trial in Houston (Tivozanib, Nivolumab)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 19, 2023

    Carcinoma, Renal Cell Trial (Orellanine)

    Not yet recruiting
    • Carcinoma, Renal Cell
    • (no location specified)
    Jan 25, 2023

    Renal Cell Carcinoma Trial in Haifa (PROSENSE™)

    Active, not recruiting
    • Renal Cell Carcinoma
    • PROSENSE™
    • Haifa, Israel
    • +1 more
    Dec 21, 2022

    First-line Treatment of Non-clear Renal Cell Carcinoma Trial (Fruquintinib combined with Serplulimab)

    Not yet recruiting
    • First-line Treatment of Non-clear Renal Cell Carcinoma
    • Fruquintinib combined with Serplulimab
    • (no location specified)
    Apr 16, 2023

    Renal Cell Carcinoma Trial in Beijing, Seoul (RO7247669, Tiragolumab, Pembrolizumab)

    Recruiting
    • Renal Cell Carcinoma
    • Beijing, China
    • +1 more
    Mar 28, 2023

    Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104)

    Completed
    • Clear Cell Renal Cell Carcinoma
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Feb 6, 2023

    RCC, Renal Cell Carcinoma Trial in Dallas (Cabozantinib 80 MG, Cabozantinib 40Mg Tab, Nivolumab)

    Not yet recruiting
    • RCC
    • Renal Cell Carcinoma
    • Cabozantinib 80 MG
    • +2 more
    • Dallas, Texas
      UT Southwestern Medical Center
    Jul 3, 2023

    Oligometastatic Renal Cell Carcinoma Trial in Houston (Pembrolizumab, Radiation therapy)

    Not yet recruiting
    • Oligometastatic Renal Cell Carcinoma
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 21, 2023

    Metastatic and/or Advanced Renal Cell Carcinoma, Treated With

    Completed
    Has Results
    • Carcinoma
    • Renal Cell
    • London, United Kingdom
      Pfizer UK
    Jan 9, 2023

    Renal Cell Carcinoma Trial in Philadelphia (Pembrolizumab infusion, Lenvatinib tablet)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Pembrolizumab infusion
    • Lenvatinib tablet
    • Philadelphia, Pennsylvania
      Abramson Cancer Center at University of Pennsylvania
    Feb 8, 2023

    Renal Cell Carcinoma Trial in Switzerland (nivolumab, ipilimumab)

    Active, not recruiting
    • Renal Cell Carcinoma
    • Aarau, Switzerland
    • +13 more
    Oct 17, 2022

    Renal Cancer, Kidney Cancer, Renal Cell Carcinoma Trial in Aurora (Axitinib, Pembrolizumab)

    Not yet recruiting
    • Renal Cancer
    • +3 more
    • Aurora, Colorado
      University of Colorado Cancer Center
    Jul 24, 2023

    Non-clear Renal Cell Carcinoma Trial in Nanjing, Nanning (Toripalimab, Axitinib)

    Recruiting
    • Non-clear Renal Cell Carcinoma
    • Nanjing, Jiangsu, China
    • +1 more
    Mar 13, 2023

    Fumarate Hydratase Deficient Renal Cell Carcinoma Trial (Tislelizumab, Lenvatinib)

    Not yet recruiting
    • Fumarate Hydratase Deficient Renal Cell Carcinoma
    • (no location specified)
    May 18, 2023

    Renal Cell Carcinoma (RCC) Trial in Birmingham (Trans-arterial embolization (TAE))

    Not yet recruiting
    • Renal Cell Carcinoma (RCC)
    • Trans-arterial embolization (TAE)
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Dec 5, 2022

    Carcinoma, Renal Cell Trial in United States (Belzutifan)

    Recruiting
    • Carcinoma, Renal Cell
    • Boston, Massachusetts
    • +3 more
    Jan 27, 2023

    Renal Cell Carcinoma Trial (Neoadjuvant Lenvatinib, Neoadjuvant Pembrolizumab, Radical nephrectomy, IVC thrombectomy,

    Not yet recruiting
    • Renal Cell Carcinoma
    • Neoadjuvant Lenvatinib
    • +3 more
    • (no location specified)
    Dec 23, 2022

    Renal Cancer, Renal Cell Carcinoma, Renal Cell Cancer Metastatic Trial

    Recruiting
    • Renal Cancer
    • +2 more
      • Amsterdam, Noord Holland, Netherlands
        Amsterdam UMC locatie VUMC
      Jan 20, 2023

      Primary and Metastatic Tumors in Renal Cell Carcinoma and

      Recruiting
      • Renal Cell Carcinoma
      • +4 more
      • Immune checkpoint inhibitor targeting PD1
      • Philadelphia, Pennsylvania
        Fox Chase Cancer Center - Philadelphia
      Jan 27, 2023

      Develop Circulating Exosomes as Predictive Biomarkers for

      Recruiting
      • Renal Cell Carcinoma
      • Other: Blood and Urine Collection
      • Hangzhou, China
        An Zhao
      Jan 30, 2023

      Metastatic Clear Cell Renal Cell Carcinoma, With Positive PSMA Expression at Tumor Sites Trial (177Lu-PSMA-1

      Not yet recruiting
      • Metastatic Clear Cell Renal Cell Carcinoma
      • With Positive PSMA Expression at Tumor Sites
      • 177Lu-PSMA-1 (radiopharmaceutical)
      • (no location specified)
      Sep 26, 2023

      From Clear Cell Renal Cell Carcinoma

      Recruiting
      • Clear Cell Renal Cell Carcinoma
      • Urinary sample
      • Saint-Étienne, France
        Chu Saint-Etienne
      Jul 13, 2022

      Urothelial Carcinoma, Renal Cell Carcinoma, Melanoma Trial (BGB-A445, Tislelizumab)

      Not yet recruiting
      • Urothelial Carcinoma
      • +2 more
      • (no location specified)
      Dec 15, 2022